Page 24 - Sera Prognostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Elekta AB (publ) (OTCMKTS:EKTAY – Get Rating) and Sera Prognostics (NASDAQ:SERA – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, institutional ownership and dividends. Institutional and Insider Ownership 46.7% of Sera Prognostics shares […]

Sera Prognostics Inc (NASDAQ:SERA – Get Rating) insider John J. Boniface sold 2,725 shares of the company’s stock in a transaction dated Monday, March 14th. The shares were sold at an average price of $3.94, for a total transaction of $10,736.50. The sale was disclosed in a legal filing with the SEC, which can be […]

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative...

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative...

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative...